Invention Grant
- Patent Title: Imidazole and triazole KRAS inhibitors
-
Application No.: US17700923Application Date: 2022-03-22
-
Publication No.: US12077539B2Publication Date: 2024-09-03
- Inventor: Chao Qi , Xiaozhao Wang , Wenqing Yao
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Lathrop GPM LLP
- Agent Brian C. Trinque; Nicole Sassu
- Main IPC: C07D471/14
- IPC: C07D471/14 ; A61K31/4375 ; A61P35/00
Abstract:
Disclosed are compounds of Formula I, methods of using the compounds for inhibiting KRAS activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with KRAS activity such as cancer.
Public/Granted literature
- US20220306633A1 IMIDAZOLE AND TRIAZOLE KRAS INHIBITORS Public/Granted day:2022-09-29
Information query
